Results 291 to 300 of about 92,601 (353)
#1689903 An Unusual Cause of Primary Adrenal Insufficiency: Adrenal Tuberculosis [PDF]
Juan Gabriel Melendez-Rivera+1 more
openalex +1 more source
Novel Findings in Pediatric and Adolescent Patients With Cancer and a Germline SMARCA4 Variant
ABSTRACT Introduction SMARCA4 is a known susceptibility gene for malignant rhabdoid tumors (MRT) in children and small cell carcinoma of the ovary hypercalcemic type (SCCOHT) in young females and women. Recently, a novel association between germline SMARCA4 variants and predisposition to neuroblastoma was proposed.
Nienke van Engelen+12 more
wiley +1 more source
Subcellular distribution and arterio-venous differences of synthetic 3H-ß1-23-Corticotrophin-23-amideacetate in the adrenal of rats [PDF]
Müller, O. A., Scriba, Peter Christian
core
Abstract Background and Purpose Nervonic acid plays a vital role in maintaining normal brain and neuronal function. Nervonic acid has gained increasing attention because of its potential neuroprotective and anti‐inflammatory properties. Nonetheless, the beneficial effects of nervonic acid are yet to be fully investigated. Adrenomyeloneuropathy (AMN), a
Chenxu Li+2 more
wiley +1 more source
NEW-ONSET PRIMARY ADRENAL INSUFFICIENCY AFTER COVID-19: CASE REPORT. [PDF]
Kayhan Y+4 more
europepmc +1 more source
ABSTRACT Introduction Worldwide, combined 17‐hydroxylase/17,20‐lyase deficiency (CYP17D) is a rare form of congenital adrenal hyperplasia, but it is the second most prevalent type in Brazil. An absence of sexual differentiation and hypergonadotropic hypogonadism arise from a reduction in the usual pattern of sex steroid formation in the adrenals and ...
Rafaela Fontenele+9 more
wiley +1 more source
ABSTRACT Background Replacement therapy with modified‐release hydrocortisone capsules (MRHC) restores the physiological circadian cortisol rhythm in congenital adrenal hyperplasia (CAH). Aims To determine the relative bioavailability of MRHC and evaluate an optimal protocol to switch CAH patients from standard therapy to MRHC.
Richard John M. Ross+15 more
wiley +1 more source